Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16–17 may 2019, Regensburg, Germany What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?

Antithymocyte globulin (ATG) is a widely accepted part of the conditioning regimen applied in the setting of hematopoietic stem cell transplantation (HSCT) to prevent graft rejection and graft-versus-host disease. Although weight-based dosing of ATG has been introduced to optimize ATG dosing, substa...

詳細記述

書誌詳細

主要な著者:	Lisa V.E. Oostenbrink, Cornelia M. Jol-van der Zijde, Anja M. Jansen-Hoogendijk, Emma S. Pool, Astrid G.S. van Halteren, Dirk Jan A.R. Moes, Robbert G.M. Bredius, Alex B. Mohseny, Frans J.W. Smiers, Maarten J.D. van Tol, Marco W. Schilham, Arjan C. Lankester
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wolters Kluwer Medknow Publications 2020-04-01
シリーズ:	Hematology/Oncology and Stem Cell Therapy
主題:	atg grafalon thymoglobulin haploidentical hsct pediatrics sickle cell disease
オンライン･アクセス:	https://journals.lww.com/10.1016/j.hemonc.2019.12.003
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!